A Phase 1b, Multicenter, Open Label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant (AT-1501-K102)

Principal Investigator

Dr Paul Harden

Contact us

Email: renalandtransplanttrials@ouh.nhs.uk

IRAS number

1004210